Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 0.50 |
| ▸ | PGK2 | P07205 | 1/20 | 0.50 |
| ▸ | PGD | P52209 | 3/20 | 0.47 |
| ▸ | MPI | P34949 | 1/20 | 0.47 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.42 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.42 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.42 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14278848 | 0.98 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL6655023 | 0.98 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL7341 | 0.98 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL7340 | 0.98 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL14278847 | 0.98 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL213379 | 0.98 | PGK1 (0.52) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL4112816 | 0.95 | PGK1 (0.50) | PGK1PGK2PGDMPILPAR5 | |
| Iodide SCHEMBL7627762 | 0.95 | PGK1 (0.50) | PGK1PGK2PGDMPILPAR5 | |
| SCHEMBL1134754 | 0.95 | PGK1 (0.50) | PGK1PGK2PGDMPILPAR5 | |
| Water SCHEMBL11070947 | 0.95 | PGK1 (0.50) | PGK1PGK2PGDMPILPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105944149-A | Absorbable cartilage repair system and preparation method thereof | 齐鲁工业大学 | 2016-09-21 | — | — | CN | claimed |
| CN-105902482-A | Patches and methods for the transdermal delivery of a therapeutically effective amount of iron | FE3医学有限公司 | 2016-08-31 | — | — | CN | claimed |
| US-9282735-B2 | Use of EDDS and calcium ions as enchancers of molluscicidal activity | INNOSPEC LIMITED (GB) | 2016-03-15 | — | — | US | claimed |
| US-20150237850-A1 | COMPOSITION, METHOD AND USE | W. NEUDORFF GMBH KG (DE) | 2015-08-27 | — | — | US | claimed |
| EP-2389065-B1 | USE OF EDDS AND CALCIUM IONS AS ENHANCERS OF MOLLUSCICIDAL ACTIVITY | INNOSPEC LTD (GB) | 2015-08-19 | — | — | EP | claimed |
| US-9044009-B2 | Use of EDDS and calcium ions as enhancers of molluscicidal activity | W.NEUDORFF GMBH KG (DE) | 2015-06-02 | — | — | US | claimed |
| CN-103690561-A | Preparation method of oral liquid | KANGSHOU PHARMACY CO LTD HUNAN | 2014-04-02 | — | — | CN | claimed |
| CN-102198151-B | Bulk pharmaceutical of swine astragalus polyferose and preparation method thereof | TIANJIN ZHONGAO BIOTECHNOLOGY CO LTD | 2013-02-13 | — | — | CN | claimed |
| CN-102198152-B | Injection containing astragalus polysaccharide-iron complex for swine, and preparation method thereof | TIANJIN ZHONGGAO BIOTECHNOLOGY CO LTD | 2013-02-13 | — | — | CN | claimed |
| US-20120027832-A1 | USE OF EDDS AND CALCIUM IONS AS ENHANCERS OF MOLLUSCICIDAL ACTIVITY | W. NEUDORFF GMBH KG (DE) | 2012-02-02 | — | — | US | claimed |
| WO-2010084361-A2 | COMPOSITION, METHOD AND USE | INNOSPEC LIMITED (GB) | 2010-07-29 | — | — | WO | claimed |
| CN-101102762-A | Compositions including iron | DRUGTECH CORP (US) | 2008-01-09 | — | — | CN | claimed |
| CN-1678293-A | Compositions and methods for treating skin conditions | AKPHARMA INC (US) | 2005-10-05 | — | — | CN | claimed |
| CN-1163126-C | Enhancement of metal molluscicides by ethylene diamine disuccinic acid | W����ŵ�� | 2004-08-25 | — | — | CN | claimed |
| US-20020136751-A1 | Naturally occurring enhancer of metal toxicants in molluscs | PURITCH GEORGE S (CA) | 2002-09-26 | — | — | US | claimed |
| EP-1052899-B1 | Enhancement of metal molluscicides by ethylene diamine disuccinic acid (EDDS) | NEUDORFF W GMBH KG (DE) | 2002-04-17 | — | — | EP | claimed |
| US-6352706-B1 | IRON, COPPER, ZINC AND/OR ALUMINUM COMPOUND; ETHYLENEDIAMINE DISUCCINIC ACID OR SALT OR COMPLEX THEREOF; AND CARRIER; STOMACH POISON | W. NEUDORFF GMBH KG (DE) | 2002-03-05 | — | — | US | claimed |
| CN-1290125-A | Enhancement of metal molluscicides by ethylene diamine disuccinic acid | NEUDORFF W GMBH KG (DE) | 2001-04-04 | — | — | CN | claimed |
| EP-1052899-A1 | ENHANCEMENT OF METAL MOLLUSCICIDES BY ETHYLENE DIAMINE DISUCCINIC ACID | W. NEUDORFF GmbH KG (DE) | 2000-11-22 | — | — | EP | claimed |
| WO-1999039576-A1 | ENHANCEMENT OF METAL MOLLUSCICIDES BY ETHYLENE DIAMINE DISUCCINIC ACID | W. NEUDORFF GMBH KG (DE) | 1999-08-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150237850-A1 | COMPOSITION, METHOD AND USE | IDUA, ATP2A3, ATP2A1 | PGK1 858/4885PGK2 887/4885PGD 100/4885 |
| US-20120027832-A1 | USE OF EDDS AND CALCIUM IONS AS ENHANCERS OF MOLLUSCICIDAL ACTIVITY | ORAI1, ATP2A1, ACMSD | PGK1 1039/4885PGK2 1613/4885PGD 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.